Medicare coverage brings hope for Alzheimer's patients seeking accessible expensive drug
KUTV - The recent FDA approval of the drug Leqembi, which slows the progression of early Alzheimer's, also triggered approval by Medicare and Medicaid, meanin |!| Salt Lake City
